Trident Texofab Ltd — Board Meeting, 13-08-2025: Board Meeting

Trident Texofab's board has approved the financial results for the quarter ended June 30, 2025. The company reported revenue from operations of 28.08 Cr and a net profit of 1.02 Cr. Additionally, CS Mehul Amareliya, Proprietor of Amareliya & Associates, has been appointed as the Secretarial Auditor for five financial years, subject to shareholder approval. These updates offer investors clarity on recent performance and underscore the company's commitment to enhancing its compliance and governance framework for the long term.